FDA Speeds Up Review Of Pfizer’s RSV Vaccine For Older Adults
But don't get your hopes up for any help this winter: The review period likely won't end until May. Meanwhile, as the "tripledemic" of RSV, flu, and covid wreaks havoc on hospitals nationwide, CDC Director Rochelle Walensky told Roll Call that the agency is running out of ways to be creative with its limited pandemic funds.